Period July -
• Net sales: 0 (0) TSEK.
• Other operating revenues: 423 (2,673) TSEK.
• Profit from financial items: -10,225 (-6,532) TSEK.
• Earnings per share: -0.52
Period January -
• Net sales: 0 (0) TSEK.
• Other operating revenues: 6,380 (8,892) TSEK.
• Profit from financial items: -36,483 (-18,587) TSEK.
• Earnings per share: -2.22
• Liquidity as per the end of the reporting period: 66,087 (35,245) TSEK.
• Equity ratio as per the end of the reporting period: 95 (83)%.
Events during the period
•
• Patent approved in the
•
Events after the period
•
• CombiGene’s Horizon 2020 project successfully completed with a final payment of approximately
Link to the report
© Modular Finance, source